Gilead and Merck provide HIV data; Dimension Capital announces $800M fund

July 21, 2026 11:30 AM EDTUpdated 11:48 AM News Briefing Gilead and Mer­ck pro­vide HIV da­ta; Di­men­sion Cap­i­tal an­nounces $800M fund ENDPOINTS Gilead and Mer­ck’s HIV da­ta: The duo will present more de­tailed re­sults of the Phase 3 tri­als of their once-week­ly oral … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER